Rensselaer Polytechnic Institute Awarded $3.3 Million Grant to Improve mRNA Purification Technology
Research aims to address a critical bottleneck in the production of mRNA therapeutics.
First Cohort of CEPM Ph.D. Students Reflect on Their Inaugural Semester
This semester, the RPI-Mt. Sinai Center for Engineering and Precision Medicine (CEPM) welcomed the inaugural cohort of students in the center’s Ph.D. program in health sciences engineering jointly offered by RPI and Icahn School of Medicine at Mount Sinai.
RPI Collaborates on First-of-its-Kind Research Study to Keep New York Lakes Healthy
RPI professor and freshwater ecology expert Kevin Rose, Ph.D., in collaboration with other researchers from Rensselaer Polytechnic Institute (RPI), the Lake George Association (LGA), and Paul Smith’s College, conducted the first ever long-term study on the environmental effects of the aquatic herbicide florpyrauxifen-benzyl (FPB), also known as ProcellaCOR.
New Research Initiative Seeks to Map Hidden Connections Between Menopause and Chronic Conditions
The Multi-Organ Approach to Address Diseases Following Estrogen Loss (MODEL) program aims to map the entire biological landscape of menopause
A New Way to Treat Cancer: Targeting the “Hedgehog” Protein’s Hidden Weakness
A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic Institute (RPI), the University of Nebraska Medical Center (UNMC), University of Binghamton, and SUNY College of Environmental Science and Forestry.
RPI Researchers Receive Prestigious Gordon Prize from National Academy of Engineering
Rensselaer Polytechnic Institute’s Georges Belfort, Ph.D., and Steven Cramer, Ph.D., both Institute Professors of Chemical and Biological Engineering, have won the 2025 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education given by the National Academy of Engineering.
RPI Researchers Aim to Manufacture mRNA More Affordably
Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.
Molecular Interactions in the Human Gut Help Regulate a Balanced Microbiome
Bacteroides are essential bacteria in the human gut, playing a crucial role in our overall health. These microorganisms offer numerous benefits to their hosts, contributing to digestion and immune function. In their quest for survival, Bacteroides species are involved in fierce competition, employing mechanisms to interact and assert dominance. Certain Bacteroides species have developed ways to inject toxins into rival cells, showcasing their adaptability.